Question 1

What are the most cited papers from Biotest (United States)?

Accepted Answer

The most cited paper from Biotest (United States) is "BT062, an Antibody-Drug Conjugate Directed Against CD138, Given Weekly for 3 Weeks in Each 4 Week Cycle: Safety and Further Evidence of Clinical Activity" (Leonard T. Heffner, Sundar Jagannath, Todd M. Zimmerman et al., 2012), with 62 citations. Next come "Review of intravenous immunoglobulin replacement therapy trials for primary humoral immunodeficiency patients" (45) and "BT062, An Antibody-Drug Conjugate Directed Against CD138, Shows Clinical Activity in Patients with Relapsed or Relapsed/Refractory Multiple Myeloma" (44).

Question 2

Which research topics does Biotest (United States) publish most on?

Accepted Answer

By volume: Microbial bioremediation and biosurfactants, Medical Device Sterilization and Disinfection, Salmonella and Campylobacter epidemiology and Peptidase Inhibition and Analysis.

Question 3

Which fields of science does Biotest (United States) work in?

Accepted Answer

In all years, 49% of research at Biotest (United States) is in Health Sciences, 34% in Life Sciences. Its largest fields are Medicine (42%), Immunology and Microbiology (13%), Biochemistry, Genetics and Molecular Biology (10%). It does 1.5× the world's share of Health Sciences.

Question 4

Is Biotest (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 100% lower than in 2018-2021.